![Charles Sermon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Sermon
Oprichter bij
MEREO BIOPHARMA GROUP PLC
Vermogen: 75 357 $ op 31-05-2026
Profiel
Charles Edward Sermon is the founder of Mereo BioPharma Group Plc, founded in 2015, holding the title of Secretary, General Counsel & Business Development.
Current jobs include Director at Mereo BioPharma 3 Ltd., Director at Mereo BioPharma 2 Ltd. since 2015, Director at Mereo BioPharma 4 Ltd. since 2017, and Trustee at Rainbow Trust Children's Charity.
Former jobs include Partner at Phase4 Partners Ltd. from 2000 to 2022, Member-Digital, Creative & Science at London Enterprise Panel from 2013 to 2016, and a position at Freshfields in 2004.
Education includes graduation from The University of Hull.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 26-03-2026 | 1.095.309 ( 0,14% ) | 75 357 $ | 31-05-2026 |
Actieve functies van Charles Sermon
| Bedrijven | Functie | Begin |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Oprichter | 01-03-2015 |
Mereo Biopharma 3 Ltd.
 Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Develops bio pharm products | Directeur/Bestuurslid | - |
Mereo BioPharma 2 Ltd.
 Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and experimental development for biotechnology | Directeur/Bestuurslid | 30-06-2015 |
Mereo BioPharma 4 Ltd.
 Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Directeur/Bestuurslid | 24-10-2017 |
Rainbow Trust Children's Charity
 Rainbow Trust Children's Charity Miscellaneous Commercial ServicesCommercial Services Provides emotional and practical support services | Directeur/Bestuurslid | - |
Eerdere bekende functies van Charles Sermon
| Bedrijven | Functie | Einde |
|---|---|---|
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million. | Lid van de Investeringscommissie | 28-02-2022 |
London Enterprise Panel | Corporate Officer/Principal | 01-01-2016 |
Opleiding van Charles Sermon
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
29
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Phase4 Partners Ltd.
Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
The University of Hull
 The University of Hull Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rainbow Trust Children's Charity
Rainbow Trust Children's Charity Miscellaneous Commercial ServicesCommercial Services Provides emotional and practical support services | Commercial Services |
Mereo BioPharma Group Plc
 Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
London Enterprise Panel | |
Mereo Biopharma 3 Ltd.
Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Develops bio pharm products | Health Technology |
Mereo BioPharma 2 Ltd.
Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and experimental development for biotechnology | Commercial Services |
Mereo BioPharma 4 Ltd.
Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Commercial Services |
